BridgeBio Pharma (BBIO) PT Raised to $110 at TD Cowen
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.72 +0.17%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
TD Cowen analyst Tyler Van Buren raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $110.00 (from $95.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Vibra Energia SA (VBBR3:BZ) PT Raised to R$43 at JPMorgan
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
